...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Wikipedia on Investor Relations: Goal is Fair Valuation

Hartland,

I completely agree. I was just providing more context.

BearDownAZ

Share
New Message
Please login to post a reply